Evidence map›Paper›PMID 23474015›Full record

ReviewNeuropharmacology2014

Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Agnes J Jasinska, Todd Zorick, Arthur L Brody, Elliot A Stein

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01721473 (Nicotinic Acetylcholine Receptor Density and Veteran Cigarette Smokers), which is not on this map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01721473 completednot on this map

Nicotinic Acetylcholine Receptor Density and Veteran Cigarette Smokers

TypeobservationalSponsorVA Office of Research and DevelopmentRan2012 to 2016Enrolled184ConditionsPositron Emission TomographyArmspositron emission tomography scan
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it, 160 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Synthetic cooling agents enhance nicotine reinforcement and mesolimbic dopamine signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  6. Describing ZYN-Related Content on TikTok: Content Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Machine Learning of Functional Connectivity to Biotype Alcohol and Nicotine Use Disorders.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cholinergic system adaptations are associated with cognitive function in people recently abstinent from smoking: a (-)-[Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Agnes J JasinskaNational Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, United States. Electronic address: jasinskaaj@mail.nih.gov.
Todd ZorickUniversity of California at Los Angeles, Department of Psychiatry, 300 UCLA Medical Plaza, Los Angeles, CA 90095, United States; VA Greater Los Angeles Healthcare System, United States.
Arthur L BrodyUniversity of California at Los Angeles, Department of Psychiatry, 300 UCLA Medical Plaza, Los Angeles, CA 90095, United States; VA Greater Los Angeles Healthcare System, United States. Electronic address: abrody@ucla.edu.
Elliot A SteinNational Institute on Drug Abuse, Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, United States. Electronic address: EStein@intra.nida.nih.gov.
National Institute on Drug Abuse · USVA Greater Los Angeles Healthcare System · US

Funding

Functional and Structural Brain Circuits Underlying SmokingZIADA000573 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI STEIN, ELLIOT A · 2010 to 2021
$19.4M
Nicotine Receptor Density & Dopamine System Function in Smokers: Treatment EffectR01DA020872 · NIDA · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI BRODY, ARTHUR · 2005 to 2013
$2.0M
Nicotinic Acetylcholine Receptor Density and Veteran Cigarette SmokersI01CX000412 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI BRODY, ARTHUR · 2013 to 2017
–
CSRD VA I01 CX000412Intramural NIH HHS Z99 DA999999NIDA NIH HHS R01 DA020872
6 · The paper itself

Abstract

Substantial evidence demonstrates both nicotine's addiction liability and its cognition-enhancing effects. However, the neurobiological mechanisms underlying nicotine's impact on brain function and behavior remain incompletely understood. Elucidation of these mechanisms is of high clinical importance and may lead to improved therapeutics for smoking cessation as well as for a number of cognitive disorders such as schizophrenia. Neuroimaging techniques such as positron emission tomography (PET), single photon emission computed tomography (SPECT), and functional magnetic resonance imaging (fMRI), which make it possible to study the actions of nicotine in the human brain in vivo, play an increasingly important role in identifying these dual mechanisms of action. In this review, we summarize the current state of knowledge and discuss outstanding questions and future directions in human neuroimaging research on nicotine and tobacco. This research spans from receptor-level PET and SPECT studies demonstrating nicotine occupancy at nicotinic acetylcholine receptors (nAChRs) and upregulation of nAChRs induced by chronic smoking; through nicotine's interactions with the mesocorticolimbic dopamine system believed to mediate nicotine's reinforcing effects leading to dependence; to functional activity and connectivity fMRI studies documenting nicotine's complex behavioral and cognitive effects manifest by its actions on large-scale brain networks engaged both during task performance and at rest. This article is part of the Special Issue Section entitled 'Neuroimaging in Neuropharmacology'.

Indexed as

AnimalsBrainCognitionDopamineHumansNeuroimagingNicotineNicotinic AgonistsReceptors, NicotinicTobacco Use DisorderDopamineNicotineNicotinic AgonistsReceptors, NicotinicAddictionCognitionDopaminefMRINicotinePETSmokingSPECTTobacco

Identifiers

PMID23474015
PMCPMC3710300
OpenAlexW2013028614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.